Evaluation of a Predictive Low-Glucose Management System In-Clinic

Diabetes Technology and Therapeutics

Volumn 19, Issue 5, 2017, Pages 288-292

  Buckingham, Bruce A ^a   Bailey, Timothy S ^b   Christiansen, Mark ^c   Garg, Satish ^d   Weinzimer, Stuart ^e   Bode, Bruce ^f   Anderson, Stacey M ^g   Brazg, Ronald ^h   Ly, Trang T ^a   Kaufman, Francine R ⁱ  

^a STANFORD UNIVERSITY   (United States)

^b AMCR Institute   (United States)

^c Diablo Clinical Research   (United States)

^d UNIVERSITY OF COLORADO DENVER   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f Atlanta Diabetes Association   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h Rainier Clinical Research Center   (United States)

ⁱ Medtronic   (United States)

Author keywords

Artificial pancreas; Hypoglycemia; Sensor augmented pump

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; NOCTURNAL HYPOGLYCEMIA; PRIORITY JOURNAL; ADVERSE DEVICE EFFECT; ALGORITHM; AMBULATORY MONITORING; ANALYSIS; ARTIFICIAL PANCREAS; BLOOD; CHEMICALLY INDUCED; CLINICAL TRIAL; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; EVALUATION STUDY; HYPOGLYCEMIA; INSULIN INFUSION; MATERIALS TESTING; MIDDLE AGED; MULTICENTER STUDY; UNITED STATES; UNIVERSITY HOSPITAL; YOUNG ADULT;

ACADEMIC MEDICAL CENTERS; ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ALGORITHMS; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MATERIALS TESTING; MIDDLE AGED; MONITORING, AMBULATORY; PANCREAS, ARTIFICIAL; UNITED STATES; YOUNG ADULT;

EID: 85019549984     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2016.0319     Document Type: Article

References (20)

1. Fanelli C, Pampanelli S, Epifano L, et al.: Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans. Diabetologia 1994; 37: 797-807.
2. Buckingham B, Wilson DM, Lecher T, et al.: Duration of nocturnal hypoglycemia before seizures. Diabetes Care 2008; 31: 2110-2112.
3. Tanenberg RJ, Newton CA, Drake AJ: Confirmation of hypoglycemia in the ''dead-in-bed'' syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract 2010; 16: 244-248.
4. Barnard K, Thomas S, Royle P, et al.: Fear of hypoglycaemia in parents of young children with type 1 diabetes: a systematic review. BMC Pediatr 2010; 10: 50.
5. Choudhary P, Shin J, Wang Y, et al.: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011; 34: 2023-2025.
6. Garg S, Brazg RL, Bailey TS, et al.: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012; 14: 205-209.
7. Bergenstal RM, Klonoff DC, Garg SK, et al.: Thresholdbased insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013; 369: 224-232.
8. Ly TT, Nicholas JA, Retterath A, et al.: Analysis of glucose responses to automated insulin suspension with sensoraugmented pump therapy. Diabetes Care 2012; 35: 1462-1465.
9. Buckingham B, Chase HP, Dassau E, et al.: Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 2010; 33: 1013-1017.
10. Buckingham B, Cobry E, Clinton P, et al.: Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther 2009; 11: 93-97.
11. Buckingham BA, Cameron F, Calhoun P, et al.: Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther 2013; 15: 622-627.
12. Buckingham BA, Raghinaru D, Cameron F, et al.: Predictive low-glucose insulin suspension reduces duration of nocturnal hypoglycemia in children without increasing Ketosis. Diabetes Care 2015; 38: 1197-1204.
13. Maahs DM, Calhoun P, Buckingham BA, et al.: A randomized trial of a home system to reduce nocturnal hypoglycemia in type 1 diabetes. Diabetes Care 2014; 37: 1885-1891.
14. Abraham MB, de Bock M, Paramalingam N, et al.: Prevention of insulin-induced hypoglycemia in type 1 diabetes with predictive low glucose management system. Diabetes Technol Therap 2016; 18: 436-443.
15. Choudhary P, Olsen BS, Conget I, et al.: Hypoglycemia prevention and user acceptance of an insulin pump system with predictive low glucose management. Diabetes Technol Therap 2016; 18: 288-291.
16. Calhoun PM, Buckingham BA, Maahs DM, et al.: Efficacy of an overnight predictive low-glucose suspend system in relation to hypoglycemia risk factors in youth and adults with type 1 diabetes. J Diabetes Sci Technol 2016; 10: 1216-1221.
17. Thabit H, Tauschmann M, Allen JM, et al.: Home use of an artificial beta cell in type 1 diabetes. N Engl J Med 2015; 373: 2129-2140.
18. Thabit H, Lubina-Solomon A, Stadler M, et al.: Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study. Lancet Diabetes Endocrinol 2014; 2: 701-709.
19. Hovorka R, Elleri D, Thabit H, et al.: Overnight closedloop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014; 37: 1204-1211.
20. Danne T, Tsioli C, Kordonouri O, et al.: The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise. Diabetes Technol Therap 2014; 16: 338-347.